Casdin Partners Master Fund, L.P. bought BLFS

April 30, 2024 · Form 4 insider transaction

Casdin Partners Master Fund, L.P. bought 150,000 shares of BioLife Solutions, Inc. at $17.54 per share, a transaction worth $2.63M. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
150,000
Price
$17.54
Total value
$2.63M
Role
SecurityCommon Stock, par value $.001 per share
Transaction codeJ: J
Transaction dateApril 30, 2024
Filing dateMay 2, 2024
Shares owned after8,707,165
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a cross-trade, pursuant to which a client of Casdin Capital, LLC ("Casdin Capital") transferred 150,000 shares of common Stock, par value $.001 per share to Casdin Partners Master Fund, L.P. (the "Master Fund").; The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

View the original Form 4 on SEC EDGAR
Casdin Partners Master Fund, L.P. bought BLFS: April 30, 2024 | Insider Trading Screener